The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases
M. Catinon (Villeurbanne, France), J. Mornex (Lyon, France), V. Cottin (Lyon, France), R. Elisabeth (Villeurbanne, France), F. Thivolet (Bron, France), S. Marchand-Adam (Tours, France), S. Jouneau (Rennes, France), M. Kerjouan (Rennes, France), A. Sale (Rennes, France), D. Israel-Biet (Paris, France), J. Vergnon (Saint-Etienne, France), N. Freymond (Lyon, France), S. Cofta (Poznan, Poland), J. Müller-Quernheim (Freiburg, Germany), G. Fouilloux (Villeurbanne, France), V. Massardier (Villeurbanne, France), A. Trunfio-Sfarghiu (Villeurbanne, France), Y. Song (Beijing, China), A. Auroux (Villeurbanne, France), M. Veltkamp (Nieuwegein, Netherlands), M. Vincent (Villeurbanne, France)
Source: International Congress 2019 – Sarcoidosis: a multifaceted disease that is difficult to manage
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Catinon (Villeurbanne, France), J. Mornex (Lyon, France), V. Cottin (Lyon, France), R. Elisabeth (Villeurbanne, France), F. Thivolet (Bron, France), S. Marchand-Adam (Tours, France), S. Jouneau (Rennes, France), M. Kerjouan (Rennes, France), A. Sale (Rennes, France), D. Israel-Biet (Paris, France), J. Vergnon (Saint-Etienne, France), N. Freymond (Lyon, France), S. Cofta (Poznan, Poland), J. Müller-Quernheim (Freiburg, Germany), G. Fouilloux (Villeurbanne, France), V. Massardier (Villeurbanne, France), A. Trunfio-Sfarghiu (Villeurbanne, France), Y. Song (Beijing, China), A. Auroux (Villeurbanne, France), M. Veltkamp (Nieuwegein, Netherlands), M. Vincent (Villeurbanne, France). The Minapild Study Project: New tools to identify causes and prevent Interstitial Lung Diseases. 1392
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience. Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms Year: 2018
Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used Source: International Congress 2017 – Rare diseases Year: 2017
Multicenter Registry of Interstitial Lung Diseases in Brazil Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside Year: 2019
The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic. Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020
Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration Source: Eur Respir J, 53 (3) 1900217; 10.1183/13993003.00217-2019 Year: 2019
DANILDA – The First Danish National Interstitial Lung Disease Registry Source: International Congress 2019 – Interstitial lung disease registries Year: 2019
Characteristics of Connective Tissue Diseases Associated Interstitial Lung Diseases - A Single Centre Study in Sri Lanka Source: Virtual Congress 2021 – Interstitial lung disease, COVID-19 and friends Year: 2021
Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer Source: Virtual Congress 2020 – Screening and early lung cancer Year: 2020
ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly Source: ERJ Open Res, 6 (4) 00143-2020; 10.1183/23120541.00143-2020 Year: 2020
Implementation of FAST strategy in the National Center for Tuberculosis and Lung Diseases (NCTLD) in Georgia Source: International Congress 2018 – Tuberculosis transmission and screening strategies Year: 2018
Singing for Lung Health: Evaluation of the British Lung Foundation programme. Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques Year: 2018
Impact of a Bayesian approach on the diagnosis of Interstitial Lung Diseases Source: International Congress 2019 – Biomarkers of idiopathic interstitial pneumonia Year: 2019
Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function Year: 2021
The Disease Burden of Bronchiectasis in Korea: A National Database Study Source: International Congress 2019 – Tuberculosis epidemiology, bronchiectasis, other infections and spirometry Year: 2019
The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration Source: Eur Respir J, 52 (6) 1801855; 10.1183/13993003.01855-2018 Year: 2018
Update on CADSET (Chronic Airway Disease Early Stratification) Clinical Research Collaboration Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020
Late Breaking Abstract - CPAnet Registry – An International Chronic Pulmonary Aspergillosis Registry Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond Year: 2020
GPs Meet Rare Lung Disorders Task Force factsheet: childhood interstitial lung disease Source: Breathe 2014; 10:173-175 Year: 2014
Hospitalisation pattern in Interstitial Lung Diseases: a claims data study Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018